Sunshine Biopharma Inc (SBFM)

[kingbee]

The offering doesn't "fail" for Aegis. They get a percentage of the money raised- and that is a single digit return. You can call that a "discount" but it is in fact a fee. The idea that there will be a 50% to 70% discount to the stock price is silly. All shares bought by Aegis (and they have the right to purchase up to 15% of the float per the S-1) will be bought at market price.

We are playing with the big boys here. This is not the typical stinky pinky transaction that you are used to critiquing.